1. Introduction Evaluating the Impact of the Condition
Medial epicondylitis, or Golfer’s Elbow, is a condition that affects a large patient population, and it is easy to see why. Patients experience constant pain on the inside of the elbow and along the forearm. This pain inhibits the ability to grip and carry out daily tasks. Typing becomes impossible. The pain, because of its constant nature, worsens the patients condition psychologically, creating an overall negative effect on their life. Clinically, the pain proves to be a tough challenge. The community of practitioners is beginning to realize the importance to go beyond the temporary solutions that currently exist. With the Stem Cell treatment, the outlook is promising. Using biological agents such as UC-MSCs, practitioners will regain the ability to reverse the degeneration process that structural degeneration entails. This treatment will impact the structural failing of the tissue, compared to the treatment that only deals with the symptoms of the condition.
2. Analyzing the Microstructural Pathology
To understand the cause of Golfer’s Elbow, analysis of the microstructure of the tendon is necessary. The flexor tendon at the medial epicondyle undergoes repetitive eccentric tensile loading. Within the tendon, this combination of loading and a tensile component causes micro trauma. This will initiate an acute inflammatory response as a repair mechanism. However, in the presence of constant loading or stress, the healing process becomes arrested and fails without Stem Cell intervention like UC-MSCs. This is angiofibroblastic tendinosis. During the process, the pathology affects the tenocytes and the tendon. The organized and healthy collagen fibers of type I are slowly replaced with a type of collagen that is disorganized and inferior, type III. The vascular supply also becomes affected. In Golfer’s Elbow, hypoxia leads to a nutrient deficit that hinders endogenous Stem Cell tissue regeneration and ultimately forms a disordered extracellular matrix that predisposes the tendon to fail, which UC-MSCs aim to correct.
3. Assessing Conventional Management Protocols
Conventional in-clinic management begins with conservative approaches. Physicians promote rest, administer nonsteroidal anti-inflammatory drugs (NSAIDs), and prescribe physical rehabilitation. If these measures fail, the next tier of treatment is the corticosteroid injection to reduce inflammation. The drawbacks to these orthodox practices are numerous. Pharmaceutical analgesics treat symptoms, but ignore the progressive and destructive clinical diagnosis. Corticosteroid injections, given the repeated nature of the procedure necessary to manage the baseline mechanical deficiency, increase tendon atrophy. Debridement is a surgical intervention and the last tier of management. This, as with all other invasive surgical procedures, requires a long rehabilitation. The efficacy of this management is uncertain. Among the many unaddressed clinical concerns is the lack of an adequate Stem Cell treatment, utilizing UC-MSCs, to promote the biological healing of Golfer’s Elbow.
4. The Scientific Rationale for Deploying Stem Cell Therapies
As a biological healing intervention, Stem Cell therapies have the capacity to regenerate and therefore, fill this clinical void. The existing research supports the application of umbilical cord mesenchymal Stem Cells (UC-MSCs) in this arena due to their superior regenerative abilities. UC-MSCs, unlike other mesenchymal Stem Cells, have the ability to rapidly promote healing in the injured Golfer’s Elbow by inducing paracrine signaling and releasing growth factors. In addition to their regenerative ability, UC-MSCs have the unique ability to rapidly shift the inflammation cycle and reduce the symptoms of chronic inflammation, as evidenced by their ability to reduce pro-inflammatory cytokines at the site of injury. Influencing tenocyte activity, UC-MSCs also encourage the production of collagen I. This type of collagen I fibers replace disorganized scar tissue with a remodeled, strong tendon. UC-MSCs also produce vascular endothelial growth factor (VEGF) to induce angiogenesis. This helps deliver oxygen to previously tissue with no blood flow. Combined, these factors demonstrate that the use of Stem Cell therapy for Golfer’s Elbow has a greater positive impact than the currently available therapies, which only address the symptoms of the condition, if at all.
Figure 1: The Scientific Rationale for Deploying Stem Cell Therapies compared with Conventional Management Protocols
5. Future Trends of Regenerative Medicine in Thailand
New biological therapies have the potential to transform Orthopedic Medicine in Thailand. Thailand has expanded its health care infrastructure to include modern cellular laboratories. Regulatory agencies have started to implement flexible policies regarding the progressive therapeutic use of advanced technologies. Thai medical Stem Cell researchers have begun large-scale clinical studies that will examine the effects of UC-MSCs on chronic tendon pathologies such as Golfer’s Elbow. The availability of high-quality, safe, and affordable medical services has supported the development of an international medical services system. Personalized Stem Cell therapy in Thailand’s leading clinics is an almost certain outcome.
6. Comprehensive Summary of the Regenerative Paradigm
Shifts in paradigms such as Stem Cell regeneration that reconstruct Golfer’s Elbow are required to treat chronic medial epicondylitis. The first of many major shifts in orthopedics is the incorporation of advanced Stem Cell techniques. UC-MSCs have the potential to use their immunomodulatory effects to inhibit chronic Golfer’s Elbow inflammation, assist in angiogenesis, and create a collagen scaffold. With its expansive medical infrastructure, Thailand is the most likely country to implement the first wide-scale use of these techniques. This advanced method guarantees total recovery of limb function, and provides patients with a definitive pathway to rehabilitate all aspects of their physical health.